Dong-E-E-Jiao Co.,Ltd.

Equities

000423

CNE0000006Y9

Pharmaceuticals

End-of-day quote Shenzhen S.E. 2024-10-08 5-day change 1st Jan Change
59.60 CNY -3.40% Intraday chart for Dong-E-E-Jiao Co.,Ltd. -3.40% +20.84%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Dong-E-E-Jiao Co.,Ltd. Announces 2024 Interim Profit Distribution, Payable on 10 September 2024 Sep. 04 CI
China Resources Pharmaceutical Group Limited Announces Resignation of Bai Xiaosong as Chief Executive Officer Aug. 29 CI
Dong-E-E-Jiao H1 Profit Up 39%, Operating Income Rises 27%; Shares Climb 3% Aug. 21 MT
Dong-E-E-Jiao Co.,Ltd. Proposes Interim Dividend for the First Half of 2024 Aug. 21 CI
Dong-E-E-Jiao Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024 Aug. 16 CI
Dong-E-E-Jiao Co.,Ltd. Announces Board Appointments Aug. 08 CI
China Renaissance Starts Dong-E-E-Jiao at Buy With 83.78 Yuan Price Target Jul. 29 MT
Dong-E-E-Jiao Forecasts Up to 43% Rise in H1 Profit Jul. 12 MT
Dong-E-E-Jiao Plans Sale of 46 Million Yuan Property Jul. 08 MT
Dong-E-E-Jiao Co.,Ltd. Approves Cash Dividend for the Year 2023, Payable on 12 June 2024 May. 24 CI
Dong-E-E-Jiao Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 Apr. 25 CI
Dong-E-E-Jiao Forecasts Up to 55% Jump in Q1 Profit Apr. 12 MT
Dong-E-E-Jiao's Profit Jumps 47.6% in 2023 Mar. 22 MT
Dong-E-E-Jiao Co.,Ltd. Proposes Cash Dividend Mar. 21 CI
Dong-E-E-Jiao Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 Mar. 21 CI
Dong-E-E-Jiao Co.,Ltd.'s Equity Buyback announced on January 2, 2024, has closed with 1,512,400 shares, representing 0.23% for CNY 75.87 million. Jan. 24 CI
Tranche Update on Dong-E-E-Jiao Co.,Ltd.'s Equity Buyback Plan announced on January 2, 2024. Jan. 24 CI
Dong-E-E-Jiao Co.,Ltd. announces an Equity Buyback for 1,660,000 shares, for CNY 124.2 million. Jan. 02 CI
Dong-E-E-Jiao Co.,Ltd. authorizes a Buyback Plan. Dec. 30 CI
Dong-E-E-Jiao's Nine-Moth Profit Rises on Higher Revenue 23-10-31 MT
Dong-E-E-Jiao Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 23-10-30 CI
Dong-E-E-Jiao Expects January-September Attributable Profit to Rise Up to 60% 23-10-10 MT
Dong-E-E-Jiao Co.,Ltd. Provides Earnings Guidance for the Nine Months Ended 30 September 2023 23-10-10 CI
Dong-E-E-Jiao's H1 Attributable Profit Surges 72% 23-08-06 MT
Dong-E-E-Jiao Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 23-08-06 CI
Chart Dong-E-E-Jiao Co.,Ltd.
000423: Dynamic Chart
Logo Dong-E-E-Jiao Co.,Ltd.
Dong-E-E-Jiao Co., Ltd. specializes in the manufacturing and marketing of Chinese traditional medicines and health products. The products are primarily for deficiencies in the blood, immunodeficiency, indigestion, insomnia and fatigue.
Employees
3,678
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
59.60CNY
Average target price
76.13CNY
Spread / Average Target
+27.74%
Consensus
  1. Stock Market
  2. Equities
  3. 000423 Stock
  4. News Dong-E-E-Jiao Co.,Ltd.
  5. UBS Adjusts Dong-E-E-Jiao's Price Target to 39.3 Yuan From 37.5 Yuan, Keeps at Neutral